These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 22422807

  • 21. Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.
    Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH, Zivadinov R.
    J Neuroimaging; 2011 Jul; 21(3):210-8. PubMed ID: 20412395
    [Abstract] [Full Text] [Related]

  • 22. Comparison of diffusion tensor imaging and voxel-based morphometry to detect white matter damage in Alzheimer's disease.
    Yoon B, Shim YS, Hong YJ, Koo BB, Kim YD, Lee KO, Yang DW.
    J Neurol Sci; 2011 Mar 15; 302(1-2):89-95. PubMed ID: 21168157
    [Abstract] [Full Text] [Related]

  • 23. No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.
    Donohue K, Cox JL, Dwyer MG, Aliotta R, Corwin M, Weinstock-Guttman B, Ann Yeh E, Zivadinov R.
    J Neuroimaging; 2014 Mar 15; 24(1):63-7. PubMed ID: 23317029
    [Abstract] [Full Text] [Related]

  • 24. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
    Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL.
    J Neurol Sci; 2009 Jul 15; 282(1-2):72-9. PubMed ID: 19232641
    [Abstract] [Full Text] [Related]

  • 25. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD, Daams M, Pouwels PJ, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H.
    Radiology; 2014 Sep 15; 272(3):832-42. PubMed ID: 24761837
    [Abstract] [Full Text] [Related]

  • 26. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.
    Zhang Y, Metz LM, Yong VW, Mitchell JR.
    J Neurol Sci; 2010 Oct 15; 297(1-2):76-81. PubMed ID: 20708201
    [Abstract] [Full Text] [Related]

  • 27. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.
    Ann Neurol; 2008 Sep 15; 64(3):247-54. PubMed ID: 18570297
    [Abstract] [Full Text] [Related]

  • 28. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC, Pagani E, Rodegher M, Colombo B, Preziosa P, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2019 Feb 15; 25(2):204-216. PubMed ID: 29173009
    [Abstract] [Full Text] [Related]

  • 29. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Blumhagen JO, Egger H, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Hirsch J, Kappos L, Nichols TE, Radue EW, Borgwardt SJ.
    Hum Brain Mapp; 2010 Oct 15; 31(10):1542-55. PubMed ID: 20108225
    [Abstract] [Full Text] [Related]

  • 30. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 31. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.
    Inglese M, Ge Y, Filippi M, Falini A, Grossman RI, Gonen O.
    Neuroimage; 2004 Apr 15; 21(4):1825-9. PubMed ID: 15050603
    [Abstract] [Full Text] [Related]

  • 32. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.
    Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC.
    Neuroimage; 2007 Jan 15; 34(2):509-17. PubMed ID: 17112743
    [Abstract] [Full Text] [Related]

  • 33. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
    Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.
    Mult Scler; 2014 Feb 15; 20(2):202-13. PubMed ID: 23804554
    [Abstract] [Full Text] [Related]

  • 34. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
    Dolezal O, Gabelic T, Horakova D, Bergsland N, Dwyer MG, Seidl Z, Krasensky J, Ramasamy DP, Vaneckova M, Havrdova E, Zivadinov R.
    Clin Neurol Neurosurg; 2013 Dec 15; 115 Suppl 1():S42-8. PubMed ID: 24321154
    [Abstract] [Full Text] [Related]

  • 35. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, Veggiotti P, Comi G, Filippi M.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [Abstract] [Full Text] [Related]

  • 36. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M.
    Mult Scler; 2007 May 25; 13(4):490-501. PubMed ID: 17463072
    [Abstract] [Full Text] [Related]

  • 37. Regional specificity of magnetization transfer imaging in multiple sclerosis.
    Tjoa CW, Benedict RH, Dwyer MG, Carone DA, Zivadinov R.
    J Neuroimaging; 2008 Apr 25; 18(2):130-6. PubMed ID: 18315593
    [Abstract] [Full Text] [Related]

  • 38. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
    Datta S, Staewen TD, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA, MRI Analysis Center at Houston, CombiRx Investigators Group.
    Mult Scler Relat Disord; 2015 Mar 25; 4(2):124-36. PubMed ID: 25787188
    [Abstract] [Full Text] [Related]

  • 39. Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ.
    J Neurol Sci; 2009 Oct 15; 285(1-2):268-9; author reply 269. PubMed ID: 19500803
    [No Abstract] [Full Text] [Related]

  • 40. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb 15; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.